These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are neutrophils important host cells for Leishmania parasites? Ritter U, Frischknecht F, van Zandbergen G. Trends Parasitol; 2009 Nov; 25(11):505-10. PubMed ID: 19762280 [Abstract] [Full Text] [Related]
5. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. Chattopadhyay A, Jafurulla M. Biochem Biophys Res Commun; 2011 Dec 09; 416(1-2):7-12. PubMed ID: 22100811 [Abstract] [Full Text] [Related]
16. Rational approaches for drug designing against leishmaniasis. Shukla AK, Singh BK, Patra S, Dubey VK. Appl Biochem Biotechnol; 2010 Apr 20; 160(8):2208-18. PubMed ID: 19756413 [Abstract] [Full Text] [Related]
17. Current treatment for cutaneous leishmaniasis: a review. Palumbo E. Am J Ther; 2009 Apr 20; 16(2):178-82. PubMed ID: 19300044 [Abstract] [Full Text] [Related]
18. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. Kram D, Thäle C, Kolodziej H, Kiderlen AF. J Immunol Methods; 2008 Apr 20; 333(1-2):79-88. PubMed ID: 18313691 [Abstract] [Full Text] [Related]
19. Neutrophils and Visceral Leishmaniasis: Impact on innate immune response and cross-talks with macrophages and dendritic cells. Kupani M, Pandey RK, Mehrotra S. J Cell Physiol; 2021 Apr 20; 236(4):2255-2267. PubMed ID: 33345353 [Abstract] [Full Text] [Related]